0 CHECKOUT

PRODUCT FILTERS

REGION

28
22
22
22
5

COUNTRY

22
1
1

CATEGORIES

  • 89
  • 12
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

66
92
95
113

PUBLISHED

0
10
30
113

PRODUCT TYPE

56
23
16
12
2
2
1
1

Search for: "Company Financials: Alkermes, Inc."

Alkermes, Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Alkermes, Inc. Company Profile” is a comprehensive report on Alkermes, Inc.. The report provides complete information on the operations, organization structure and financial information details of...

Published:  October 2014
Price:  From

Alkermes, Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

“Alkermes, Inc. Business Profile” is a comprehensive research on the company’s operations across the value chain. The report on Alkermes, Inc. analyzes the company’s key strategies, SWOT analysis, future...

Published:  May 2016
Price:  From

Alkermes, Inc. (ALKS) - Financial and Strategic Analysis Review

Alkermes, Inc., (Alkermes) is a biotechnology company that develops and manufactures extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such...

Published:  July 2010
Price:  From

Alkermes, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization...

Published:  March 2016
Price:  From

Alkermes, Inc. - Product Pipeline Review - Q2 2011

Alkermes, Inc. – Product Pipeline Review – Q2 2011 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - Q2 2011” provides data on the Alkermes, Inc.’s...

Published:  July 2011
Price:  From

Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review

Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

Published:  July 2014
Price:  From

Alkermes, Inc. - Product Pipeline Review - H2 2011

Alkermes, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - H2 2011” provides data on the Alkermes, Inc.’s...

Published:  November 2011
Price:  From

Credit Suisse Financials 1-1 Conference - Alkermes, Inc., - Earnings Transcript

Credit Suisse Financials 1-1 Conference - Alkermes, Inc., - Earnings Transcript Thursday, November 11, 2010 06:00

Published:  November 2010
Price: 

Alkermes, Inc. - Product Pipeline Review - Q4 2010

Alkermes, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Alkermes, Inc. - Product Pipeline Review - Q4 2010

Alkermes, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Research Update: Alkermes PLC Rating Lowered To 'BB-' From 'BB'; Outlook Stable Mar 16

Abstract Ireland-based biopharmaceutical company Alkermes PLC recently announced its 2015 earnings and gave guidance for 2016. While Alkermes' 2015 operating performance was in line with our expectations,...

Published:  March 2016
Price: 

Rating and Forecast Report ALKERMES INC

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast Model...

Published:  May 2016
Price: 

Infusion Therapy Devices Market:By Type (Infusion Method,Others) By Types of Infusion Pumps (Large Volume Infusion Pumps,Others) By Accessories & Consumables (Pump Sets,I.V Sets,Others) By End Use & By Geography: 2015-2020

Infusion pumps are devices which are used to administer fluids, nutrients or medication into a patient’s body in a controlled manner. There are many different types of infusion pumps and are used for...

Published:  October 2014
Price:  From

Research Update: Alkermes PLC Rating Raised To 'BB', Outlook Stable On Better-Than-Expected Performance; First-Lien Rating Also Raised Jul 13

Abstract Alkermes' performance for the fiscal year ended March 31, 2013, exceeded our expectations, with leverage declining to less than 2x, and we expect financial metrics to further improve over...

Published:  July 2013
Price: 

Recovery Report: Alkermes Inc.'s Recovery Rating Profile Jun 11

Abstract In conjunction with Waltham, Mass.-based Alkermes Inc.'s acquisition of Elan Drug Technologies, Standard & Poor's Ratings Services assigned preliminary recovery and preliminary issue-level...

Published:  June 2011
Price: 

Alkermes Inc. Nov 11

Abstract A track record of successful internal product development; The absence of near-term patent expirations; and Barriers to competitive entry for its injectable drug delivery technology and related...

Published:  November 2011
Price: 

Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions

Recent Biotech Funding, Deals and Partnerships Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years,...

Published:  May 2014
Price:  From

CreditStats: Biotechnology--U.S. Aug 12

Companies mentioned in this report are: - Amgen Inc. - Biogen Idec Inc. - Celgene Corp. - BioMarin Pharmaceutical Inc. (Unsolicited Ratings) - Gilead Sciences Inc. - Alkermes Inc. Standard...

Published:  August 2012
Price: 

Drug Delivery Series: The Market for Injectable and Implantable Drug Delivery Systems: Volume 2

Drug Delivery Series: The Market for Injectable and Implantable Drug Delivery Systems: Volume 2 The changing climate of injectable/implantable drug delivery system development has been fostered...

Published:  October 2001
Price: 

Alkermes Inc. Assigned 'B+' Corporate Credit Rating; Outlook Is Stable Oct 11

Abstract Alkermes Inc., a Waltham, Mass.-based pharmaceutical technology company, acquired a similar operation from Elan Corp. plc for approximately $1 billion on Sept. 16, 2011, of which $450 million...

Published:  October 2011
Price: 
Loading Indicator

Our Clients

  • Dow Chemical Co Ltd.
  • The Estee Lauder Companies Inc
  • Carrefour S.A.
  • Motorola Solutions, Inc.
  • Activision Publishing, Inc.
  • 3M Company